BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Home » Authors » Jonathan Goldstein

Articles by Jonathan Goldstein

Biomed Israel 2014: Biomed Israel conference celebrates innovation in an interactive environment

June 3, 2014
By Jonathan Goldstein

MedTech Investing in Europe Conference: Swiss conference highlights European photonics technologies

May 12, 2014
By Jonathan Goldstein

Med-Tech Investing Conference: Conference focuses on the benefits of IT in support of the golden years

May 9, 2014
By Jonathan Goldstein

Report from Israel: Nazareth incubator NGT3 raising funds with lofty dual agenda

April 14, 2014
By Jonathan Goldstein

Report From Israel, Part 2 of 2: Weizmann Institute creates national center for personalized medicine

March 26, 2014
By Jonathan Goldstein

Part 1 of 2: Report from Israel: Israel upgrading its biopharma capabilities with new projects

March 25, 2014
By Jonathan Goldstein

Israel's ICI Conference describes major Digital Health 'Apportunity'

Dec. 23, 2013
By Jonathan Goldstein

The Israel Connection: Innovations in Cardiologic Interventions conference goes multidimensional

Dec. 20, 2013
By Jonathan Goldstein

Israel BrainTech Conference: Shimon Peres attributes Israel's success to never being satisfied

Oct. 25, 2013
By Jonathan Goldstein
TEL AVIV — The First Israel BrainTech Conference (IBT) being held here, is the brainchild of Israel's President Shimon Peres. When interviewed, the president tried to explain the secret of the small state's technological successes. "Well," he explained, "you'll find something very common in the Israeli character – we are never satisfied." That lack of satisfaction or complacency, he explained, was the key to getting people to think out of their comfort zone, and being prepared to make strides in directions that they might not have made otherwise. Israelis are good at these bold moves.
Read More

Israel BrainTech Conference: Brain technologies are the final frontier of human understanding

Oct. 22, 2013
By Jonathan Goldstein
Previous 1 2 3 4 5 6 7 8 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing